Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingwei Li

Showing results (201-210 of 204) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 204 results.
Epilepsia|January 28, 2025
Durable suppression of seizures in a preclinical model of KCNT1 genetic epilepsy with divalent small interfering RNABenjamin J Andreone, Jennifer Lin, Jenna Tocci, et al.
Nature|June 23, 2017
Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's diseaseJeff Sevigny, Ping Chiao, Thierry Bussière, et al.
Nature|September 2, 2016
The antibody aducanumab reduces Aβ plaques in Alzheimer's diseaseJeff Sevigny, Ping Chiao, Thierry Bussière, et al.
Nature Communications|December 31, 2024
An antibody cocktail targeting two different CD73 epitopes enhances enzyme inhibition and tumor controlJin-Gen Xu, Shi Chen, Yang He, et al.
Pageof 21

Showing results (201-210 of 204) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 204 results.
Epilepsia|January 28, 2025
Durable suppression of seizures in a preclinical model of KCNT1 genetic epilepsy with divalent small interfering RNABenjamin J Andreone, Jennifer Lin, Jenna Tocci, et al.
Nature|June 23, 2017
Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's diseaseJeff Sevigny, Ping Chiao, Thierry Bussière, et al.
Nature|September 2, 2016
The antibody aducanumab reduces Aβ plaques in Alzheimer's diseaseJeff Sevigny, Ping Chiao, Thierry Bussière, et al.
Nature Communications|December 31, 2024
An antibody cocktail targeting two different CD73 epitopes enhances enzyme inhibition and tumor controlJin-Gen Xu, Shi Chen, Yang He, et al.
Pageof 21